Company page

4d Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc. (ticker: FDMT) is a public company based in the United States, focusing on innovative therapeutic solutions. With a market capitalization of approximately $505 million, the company is engaged in advancing its proprietary gene therapy platform. 4D Molecular Therapeutics aims to address unmet medical needs through its cutting-edge research and development efforts.